• Michael F. Drummond, MCom, DPhil
  • C. Daniel Mullins, PhD
  • Associate Editors
  • Editorial Advisory Boards
  • Editorial Office
drummond_mike

Editor-in-Chief

(May 2018 – June 2020)
University of York
Heslington, York, UK
Contact Editors 

Michael F. Drummond is Professor of Health Economics and former Director of the Centre for Health Economics at the University of York. His particular field of interest is in the economic evaluation of healthcare treatments and programs. He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programs, services for people with AIDS, eye health care and pharmaceuticals. He is the author of two major textbooks and more than 550 scientific papers, has acted as a consultant to the World Health Organization and was Project Leader for the European Union Project on the Methodology of Economic Appraisal of Health Technology. He has been President of the International Society of Technology Assessment in Health Care, and ISPOR. He is currently a member of the Guidelines Review Panels of the National Institute for Health and Clinical Excellence (NICE) in the UK, and is a Principal Consultant for i3Innovus. In 2008, he received an Honorary Doctor of Science from City University, London.

Value in Health Vision Statement

Value in Health should duplicate ISPOR’s objectives to have the journal reflect the highest scientific quality as possible in the areas of methodological research and health care sciences, services, and policy, whilst maintaining the already broad appeal to the journal it has already attained, and continuing contributions from many world leaders associated with NICE, CMS, and major private health insurers around the globe.

mullins_daniel-photo

Editor-in-Chief

(May 2018 – June 2022)
University of Maryland
Baltimore, MD, USA
Contact Editors 

C. Daniel Mullins is a Professor within the Pharmaceutical Health Services Research Department at the University of Maryland School of Pharmacy. He received his BS in Economics from MIT and his MA and PhD in Economics from Duke University. His research and teaching focus on pharmacoeconomics, comparative effectiveness research, and health disparities research. He is the Principal Investigator of an NIH/NIA sponsored grant on “Response to Medicare Reimbursement Policy Change by Minority and All ESRD Patients” and the lead economist on an NIH/NHLBI grant with Elijah T. Saunders, MD. He was the Shared Resources Core Director for the NIH-sponsored University of Maryland Center for Health Disparities Research, Training, and Outreach and has served as a co-Investigator on other grants funded by AHRQ, HRSA and the NIH. He was a member of the Health Systems Research study section of the Agency for Healthcare Research and Quality from 2004 to 2006 and currently is an ad hoc Study Section member for the National Cancer Institute.

In addition to his work on federal grants, Dr Mullins has designed many cost-effectiveness analyses and budget impact models for both the pharmaceutical and insurance industries. He is Editor-in-Chief for Value in Health and is author/co-author of nearly 150 peer-reviewed articles and book chapters on pharmacoeconomics, outcomes research, and pharmaceutical policy and health disparities research in journals such as The American Journal of Managed Care, The American Journal of Public Health, Cancer, Chest, The Journal of Trauma, Health Services Research, Pharmacoeconomics, Social Science & Medicine, and Transplantation. Dr Mullins was a member of the Maryland Health Care Commission Hospital and Ambulatory Surgical Facility Report Card Steering Committee. Prior to his graduate studies, he was an Actuary and Market Researcher for the John Hancock Insurance Company. In 2002, he was the recipient of an Outstanding Service Award from the Drug Information Association and in 2006 and 2008 he received an ISPOR Service Award. In 2007, he received the Dr. Patricia Sokolove Outstanding Mentor Award from the University of Maryland, Baltimore campus-wide Graduate Student Association.

Value in Health Vision Statement

As the journal of ISPOR, Value in Health should be viewed as interdependent of the Society and mirror its aim to enhance the methods and applications within the fields of health economics and outcomes research, with its content reflecting research that is read and used for medical decision making and reflect empirical applications of readable, reliable, and advanced methodologies with actionable results and conclusions.

Value in Health Associate Editors

Contact Editors 

Sarah Acaster, PSc, MSc

(August 2018 – November 2022)
Acaster Lloyd Consulting Ltd.
London, UK

Kalipso Chalkidou, MD, PhD

(November 2018 – November 2022)
Imperial College, University of London
London, UK

Joshua Cohen, PhD

(June 2017 – June 2021)
Independent Healthcare Analyst
Boston, MA, USA

Jalpa A. Doshi, PhD

(March 2015 – March 2019)
University of Pennsylvania
Philadelphia, PA, USA

David Epstein, MSc, PhD

(November 2015 – November 2019)
University of Granada
Granada, Spain

Manuel Espinoza, PhD, MD, MSc

(February 2018 – February 2022)
Pontificia Universidad Católica de Chile
Santiago, Chile

Alex Z. Fu, PhD

(April 2016 – April 2020)
Georgetown University
Washington, DC, USA

Ron Goeree, MA

(April 2016 – April 2020)
McMaster University
Hamilton, ON, Canada

Dan Greenberg, PhD

(February 2015 – February 2019)
Ben-Gurion University of the Negev
Beer-Shiva, Israel

Fei-Yuan Sharon Hsiao, PhD

(September 2018 – September 2022)
National Taiwan University
Taipei, 10050 TAIWAN

Stacie Hudgens, MA

(July 2016 – July 2020)
Clinical Outcomes Solutions LLC
Tucson, AZ, USA

Andrew Lloyd, DPhil, BSc

(August 2015 – April 2019)
Acaster Lloyd Consulting Ltd
London, UK

Lori McLeod, PhD

(January 2017 – January 2021)
RTI Health Solutions
Research Triangle Park, NC, USA

Claire Rothery McKenna, PhD

(November 2015 – November 2019)
University of York
York, UK

Axel Muehlbacher, PhD

(September 2018 – September 2022)
Neubrandenburg University
Neubrandenburg, Germany

Richard Norman

(March 2016 – March 2020)
Curtin University
Perth, Australia

Maarten Postma, PhD

(June 2017 – June 2021)
University of Groningen
Groningen, The Netherlands

Thomas Rapp, PhD

(July 2016 – July 2020)
Harvard University
Boston, MA, USA

Lizheng Shi, PhD, MsPharm, MA

(July 2018 – July 2022)
Tulane University
New Orleans, LA, USA

Aleksandra Torbica, PhD

(November 2015 – November 2019)
Universita Bocconi,
Milan, Italy

David Vanness, PhD

(September 2018 – September 2022)
Pennsylvania State University
University Park, PA, USA

David Veenstra, PhD, PharmD

(June 2017 – June 2021)
University of Washington
Seattle, WA, USA

Allan Wailoo, PhD, BSc, MA

(April 2017 – April 2021)
University of Sheffield
Sheffield, UK

Danielle Whicher, PhD, MHS

(August 2018 – August 2022)
National Academy of Medicine
Washington, DC, USA

Value in Health Editorial Advisory Board

Alan Brennan, PhD
(March 2017 – March 2021)
University of Sheffield
Sheffield, UK

Kati Copley-Merriman, MS, MBA
(November 2014 – November 2018)
RTI-HS
Ann Arbor, MI, USA

John C. Hornberger, MD, MS
(March 2017 – March 2021)
Cedar Associates LLC
Menlo Park, CA, USA

Andrea Manca, PhD, MSc
(March 2016 – March 2020)
University of York
York, UK

Robert Ohsfeldt, PhD
(November 2017 – November 2021)
Texas A&M University (TAMU 1266)
College Station, TX, USA

Kathryn Phillips, PhD
(March 2017 – March 2021)
University of California San Francisco 
San Francisco, CA, USA

Shelby Reed, PhD, RPh
(February 2017 – January 2021)
Duke Clinical Research Institute
Durham, NC, USA

Brian Rittenhouse, PhD
(March 2016 – March 2020)
Massachusetts College of Pharmacy and Health Services
Boston, MA, USA

Paul Scuffham, PhD, BA
(March 2016 – March 2020)
Griffith University
Queensland, Australia

Johan L. Severens, PhD
(April 2016 – April 2020)
Erasmus School of Health Policy & Management
Rotterdam, The Netherlands

Value in Health Management Advisory Board

Rosanna Tarricone, PhD, MSc (chair)
Bocconi University
Milan, Italy

Gordon G. Liu, PhD 
Peking University National School of Development (NSD)
Bejing, China

Nancy Devlin
The University of Sheffield
London, UK

Jalpa A. Doshi, PhD
University of Pennsylvania
Philadelphia, PA, USA


Editorial Office

505 Lawrence Square Blvd South
Lawrenceville, NJ, USA 08648
Contact Editors 

Stephen L. Priori

Director, Publications

Lyn Beamesderfer

Associate Director, Publications & Communications

Jennifer Brandt

Editorial Assistant


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×